Anaptysbio (ANAB) EBT Margin (2016 - 2026)
Anaptysbio posted quarterly EBT Margin of 206.78% for Q1 2026, down 6532.0% year-on-year from 3.21% in Q1 2025, and down 347.09% on a QoQ basis from 83.68% in Q4 2025.
Anaptysbio (ANAB) has 11 years of EBT Margin data on file, last reported at 206.78% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 6532.0% year-over-year to 206.78%; the trailing twelve-month figure through Mar 2026 stood at 7.85% (up 17086.0% YoY), and the FY2024 full-year result was 159.25%, down 15900.0% from the prior year.
- EBT Margin for Q1 2026 stood at 206.78%, down from 83.68% in the prior quarter.
- Across five years, EBT Margin topped out at 1347.75% in Q4 2023 and bottomed at 3237.84% in Q1 2022.
- The 5-year median for EBT Margin is 425.22% (2024), against an average of 798.67%.
- Peak annual rise in EBT Margin reached 263239 bps in 2022, while the deepest fall reached 305618 bps in 2022.
- A 5-year view of EBT Margin shows it stood at 442.68% in 2022, then surged by 404 bps to 1347.75% in 2023, then slumped by 107 bps to 87.72% in 2024, then jumped by 195 bps to 83.68% in 2025, then tumbled by 347 bps to 206.78% in 2026.
- The last three EBT Margin figures came in at 206.78% (Q1 2026), 83.68% (Q4 2025), and 30.23% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 18.99% |
| 10 | Anaptysbio | 1.60 Bn | 1.31 Bn | - | -206.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -206.78% |
| Dec 31, 2025 | 83.68% |
| Sep 30, 2025 | 30.23% |
| Jun 30, 2025 | -173.34% |
| Mar 31, 2025 | -141.46% |
| Dec 31, 2024 | -87.72% |
| Sep 30, 2024 | -219.01% |
| Jun 30, 2024 | -425.22% |
| Mar 31, 2024 | -612.01% |
| Dec 31, 2023 | 1,347.75% |
| Sep 30, 2023 | -1,124.41% |
| Jun 30, 2023 | -1,151.59% |
| Mar 31, 2023 | -2,905.02% |
| Dec 31, 2022 | -442.68% |
| Sep 30, 2022 | -2,116.86% |
| Jun 30, 2022 | -2,195.07% |
| Mar 31, 2022 | -3,237.84% |
| Dec 31, 2021 | -3,075.07% |
| Sep 30, 2021 | -33.50% |
| Jun 30, 2021 | -2.15% |
| Mar 31, 2021 | -181.66% |
| Dec 31, 2020 | 56.08% |
| Mar 31, 2020 | -82.62% |
| Dec 31, 2019 | -676.17% |
| Jun 30, 2019 | -480.44% |
| Sep 30, 2018 | -319.16% |
| Dec 31, 2017 | -224.87% |
| Jun 30, 2017 | -90.43% |
| Dec 31, 2016 | -328.50% |
| Sep 30, 2016 | -119.10% |
| Jun 30, 2016 | 56.18% |
| Mar 31, 2016 | -31.35% |